Papers - SEKINE Hideharu
-
Lessons learned from mice deficient in lectin complement pathway molecules.
Ninette Genster, Minoru Takahashi, Hideharu Sekine, Yuichi Endo, Peter Garred, Teizo Fujita
Mol Immunol 61 ( 2 ) 59 - 68 2014
-
Comment on "the pro-factor D cleaving activity of MASP-1/-3 is not required for alternative pathway function".
Minoru Takahashi, Hideharu Sekine, Teizo Fujita
J Immunol 192 ( 12 ) 5448 - 5449 2014
-
Lessons learned from mice deficient in lectin complement pathway molecules.
Ninette Genster, Minoru Takahashi, Hideharu Sekine, Yuichi Endo, Peter Garred, Teizo Fujita
Mol Immunol 61 ( 2 ) 59 - 68 2014
-
Comment on "Mannan-binding lectin-associated serine protease (MASP)-1 is crucial for lectin pathway activation in human serum, whereas neither MASP-1 nor MASP-3 is required for alternative pathway function".
Minoru Takahashi, Hideharu Sekine, Yuichi Endo, Teizo Fujita
J Immunol 190 2477 2013.6
-
補体の異常値と疾患
関根 英治, 町田 豪, 坂本 夏美, 高橋 実
福島医学雑誌 63 ( 2 ) 93 - 107 2013.6（ ISSN:0016-2582 ）
-
Role of complement in a murine model of peanut-induced anaphylaxis.
Kodama T, Sekine H, Takahashi M, Iwaki D, Machida T, Kanno K, Ishida Y, Endo Y, Fujita T
Immunobiology 218 ( 6 ) 844 - 50 2013.6（ ISSN:0171-2985 ）
-
Comment on "Mannan-binding lectin-associated serine protease (MASP)-1 is crucial for lectin pathway activation in human serum, whereas neither MASP-1 nor MASP-3 is required for alternative pathway function".
Minoru Takahashi, Hideharu Sekine, Yuichi Endo, Teizo Fujita
J Immunol 190 2477 2013.6
-
The role of MASP-1/3 in complement activation
Sekine H, Takahashi M, Iwaki D, Fujita T
Adv Exp Med Biol 735 41 - 53 2013
-
補体の異常値と疾患
関根英治、町田豪、坂本夏美、高橋実
福島医学雑誌 63 ( 2 ) 93 - 107 2013
-
補体の異常値と疾患
関根英治、町田豪、坂本夏美、高橋実
福島医学雑誌 63 ( 2 ) 93 - 107 2013
-
Comment on "Mannan-binding lectin-associated serine protease (MASP)-1 is crucial for lectin pathway activation in human serum, whereas neither MASP-1 nor MASP-3 is required for alternative pathway function".
Minoru Takahashi, Hideharu Sekine, Yuichi Endo, Teizo Fujita
J Immunol 190 2477 2013
-
Comment on "Mannan-binding lectin-associated serine protease (MASP)-1 is crucial for lectin pathway activation in human serum, whereas neither MASP-1 nor MASP-3 is required for alternative pathway function".
Minoru Takahashi, Hideharu Sekine, Yuichi Endo, Teizo Fujita
J Immunol 190 2477 2013
-
The role of MASP-1/3 in complement activation.
Sekine H, Takahashi M, Iwaki D, Fujita T
Advances in experimental medicine and biology 735 41 - 53 2013（ ISSN:0065-2598 ）
-
補体の異常値と疾患
関根英治、町田豪、坂本夏美、高橋実
福島医学雑誌 63 ( 2 ) 93 - 107 2013
-
The dual role of complement in the progression of renal disease in NZB/W F1 mice and alternative pathway inhibition
Sekine H, Ruiz P, Gilkeson GS, Tomlinson S
Mol Immunol 49 317 - 323 2011.10
-
The benefit of targeted and selective inhibition of the alternative complement pathway for modulating autoimmunity and renal disease in MRL/lpr mice
Sekine H, Kinser TT, Qiao F, Martinez E, Paulling E, Ruiz P, Gilkeson GS, Tomlinson S
Arthritis Rheum 63 1076 - 1085 2011.4
-
Comment on "Reassessment of the role of mut S homolog 5 in Ig class switch recombination shows lack of involvement in cis- and trans-switching"
Sekine H, Ferreira RC, Pan-Hammarström Q, Hammarström L, Gilkeson GS, Behrens TW
J Immunol 182 4495 - 4496 2009.4
-
Role for Msh5 in the regulation of Ig class switch recombination
Sekine H, Ferreira RC, Pan-Hammarstrom Q, Graham RR, Ziemba B, de Vries SS, Liu J, Hippen K, Koeuth T, Ortmann W, Iwahori A, Elliott MK, Offer S, Skon C, Du L, Novitzke J, Lee AT, Zhao N, Tompkins JD, Altshuler D, Gregersen PK, Cunningham-Rundles C, Harris RS, Her C, Nelson DL, Hammarstrom L, Gilkeson GS, Behrens TW
Proc Natl Acad Sci USA 104 7193 - 7198 2007.4
-
Role of MHC-linked genes in autoantigen selection and renal disease in a murine model of systemic lupus erythematosus
Sekine H, Graham KL, Zhao S, Elliott MK, Ruiz P, Utz PJ, Gilkeson GS
J Immunol 177 7423 - 7434 2006.11
-
Enrichment of Anti-Glomerular Antigen Antibody-Producing Cells in the Kidneys of MRL/MpJ-Faslpr Mice
Sekine H, Watanabe H, Gilkeson GS
J Immunol 172 3913 - 3921 2004.3